Jpmorgan Chase & CO Bristol Myers Squibb CO Transaction History

Jpmorgan Chase & CO

$1.51 Trillion
Q3 2025

A detailed history of Jpmorgan Chase & CO transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Jpmorgan Chase & CO holds 86,180,664 shares of BMY stock, worth $4.03 Billion. This represents 0.26% of its overall portfolio holdings.

Number of Shares

86,180,664

Previous 86,180,664 -0.0%

Holding current value

$4.03 Billion

Previous $3.89 Billion -0.0%

% of portfolio

0.26%

Previous 0.26%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 07, 2025	SELL	$43.31 - $48.98 $947 Million - $1.07 Billion	-21,871,840 Reduced 20.24%	86,180,664 $3.89 Billion
Q1 2025 May 12, 2025	BUY	$53.9 - $63.11 $648 Million - $759 Million	12,029,292 Added 12.53%	108,052,504 $6.59 Billion
Q4 2024 Feb 12, 2025	BUY	$51.92 - $59.94 $939 Million - $1.08 Billion	18,093,184 Added 23.22%	96,023,212 $5.43 Billion
Q3 2024 Dec 26, 2024	BUY	$39.66 - $51.75 $131 Million - $171 Million	3,300,102 Added 4.42%	77,930,028 $4.03 Billion
Q3 2024 Nov 08, 2024	BUY	$39.66 - $51.75 $131 Million - $171 Million	3,300,102 Added 4.42%	77,930,028 $4.03 Billion

Q2 2024 Dec 26, 2024	SELL	$40.25 - $52.99 $133 Million - $175 Million	-3,300,102 Reduced 4.23%	74,629,926 $3.1 Billion
Q2 2024 Aug 12, 2024	SELL	$40.25 - $52.99 $571 Million - $752 Million	-14,184,197 Reduced 15.97%	74,629,926 $3.1 Billion
Q1 2024 Dec 26, 2024	BUY	$47.98 - $54.4 $522 Million - $592 Million	10,884,095 Added 13.97%	88,814,123 $4.82 Billion
Q1 2024 May 10, 2024	SELL	$47.98 - $54.4 $59.2 Million - $67.1 Million	-1,234,151 Reduced 1.37%	88,814,123 $4.82 Billion
Q4 2023 Dec 26, 2024	BUY	$48.48 - $57.85 $587 Million - $701 Million	12,118,246 Added 15.55%	90,048,274 $4.62 Billion
Q4 2023 Feb 12, 2024	SELL	$48.48 - $57.85 $324 Million - $387 Million	-6,692,109 Reduced 6.92%	90,048,274 $4.62 Billion
Q3 2023 Nov 14, 2023	SELL	$57.89 - $64.73 $381 Million - $425 Million	-6,573,182 Reduced 6.36%	96,740,383 $5.61 Billion
Q2 2023 Aug 11, 2023	BUY	$63.71 - $70.74 $427 Million - $474 Million	6,699,923 Added 6.93%	103,313,565 $6.61 Billion
Q1 2023 May 18, 2023	BUY	$65.71 - $74.53 $65.8 Million - $74.6 Million	1,000,670 Added 1.05%	96,613,642 $6.7 Billion
Q1 2023 May 11, 2023	SELL	$65.71 - $74.53 $200 Million - $227 Million	-3,050,504 Reduced 3.09%	95,612,972 $6.63 Billion
Q4 2022 Feb 13, 2023	SELL	$68.48 - $81.09 $57.2 Million - $67.7 Million	-834,677 Reduced 0.84%	98,663,476 $7.1 Billion
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $225,926 - $134 Million	1,737,893 Added 1.78%	99,498,153 $7.07 Billion
Q2 2022 Aug 11, 2022	BUY	$72.62 - $79.98 $281 Million - $310 Million	3,876,301 Added 4.13%	97,760,260 $7.53 Billion
Q1 2022 May 11, 2022	BUY	$61.48 - $73.72 $131 Million - $157 Million	2,133,783 Added 2.33%	93,883,959 $6.86 Billion
Q4 2021 Feb 10, 2022	BUY	$53.63 - $62.52 $331 Million - $386 Million	6,172,949 Added 7.21%	91,750,176 $5.72 Billion
Q3 2021 Nov 12, 2021	BUY	$59.17 - $69.31 $5.06 Billion - $5.93 Billion	85,577,227 New	85,577,227 $5.06 Billion

Others Institutions Holding BMY

# of Institutions

2,680

Shares Held

1.58B

Call Options Held

28M

Put Options Held

28.4M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $99.5B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Bristol Myers Squibb CO Transaction History